Samples of diabetes drug contain potential carcinogens, FDA says Merck markets the drug as Januvia and Janumet. (NCD)Traces of a potential carcinogen have been found in samples of a diabetes drug produced by Merck, according to the U.S. Food & Drug Administration. >> Read more trending newsSitagliptin, produced by Merck, is used by millions of people with Type 2 diabetes, The New York Times reported. The drug is used by diabetes patients to keep high blood sugar levels in check. The FDA said that traces of a potential carcinogen had been found in samples of a popular diabetes drug produced by Merck and used by millions of people, the latest instance in which impurities were detected in top-selling pharmaceutical products.

Source: New York Times August 12, 2022 02:25 UTC